Internal Medicine, Cardiovascular Disease · Macon, GA
NPI
1992749659
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
4
Medicare group memberships
Hospitals
6
Hospital affiliations
6010 Lakeside Commons Dr
Macon, GA, 31210
Phone (478) 200-8152
Groups this clinician bills Medicare through
Medicare paid, 2024
$590K
5,484 services
Medicare patients, 2024
1,507
Average age 76
Drug cost, 2024
$2.7M
15,861 prescriptions
Company payments, 2025
$819
From 14 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Amy D Kingman was code J2785 (injection, regadenoson, 0.1 mg), 924 times for 231 patients. In total Amy D Kingman billed 5,484 services in 37 codes, and Medicare paid $590K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2026-05-21.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2785 Injection, regadenoson, 0.1 mg | Office | 924 | 231 | $5.62 | $5,195 |
| 93000 Electrocardiogram | Office | 845 | 725 | $9.31 | $7,866 |
| 99214 Office E&M - Established | Office | 782 | 584 | $84.14 | $66K |
| 99213 Office E&M - Established | Office | 477 | 432 | $57.13 | $27K |
| 93306 Echocardiography (TTE/TEE) | Office | 381 | 377 | $123.11 | $47K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 302 | 151 | $228.84 | $69K |
| 93015 Electrocardiogram | Office | 276 | 276 | $46.92 | $13K |
| A9502 Technetium tc-99m tetrofosmin, diagnostic, per study dose | Office | 246 | 123 | $85.86 | $21K |
| 78492 Myocardial Perfusion Scan | Office | 151 | 151 | $1,058.49 | $160K |
| 99204 Office E&M - New | Office | 133 | 133 | $112.10 | $15K |
| 78452 Myocardial Perfusion Scan | Office | 123 | 123 | $280.75 | $35K |
| 93306 Echocardiography (TTE/TEE) | Facility | 97 | 97 | $48.86 | $4,739 |
| G0250 Physician review, interpretation, and patient management of home inr testing for patient with either mechanical heart valve(s), chronic atrial fibrillation, or venous thromboembolism who meets medicare coverage criteria; testing not occurring more frequent | Office | 94 | 11 | $6.59 | $619 |
| 93010 Electrocardiogram | Facility | 85 | 81 | $5.59 | $475 |
| J0280 Injection, aminophyllin, up to 250 mg | Office | 78 | 78 | $5.98 | $466 |
By year: 2022 $842K for 7,351 services; 2023 $653K for 6,140 services; 2024 $590K for 5,484 services.
Lab tests billed to Medicare, 2022
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 91 | 17 | $4.23 | $385 |
Medicare prescription drug claims, 2024
In 2024, the drug Amy D Kingman prescribed most often to Medicare patients was Rosuvastatin Calcium, with 1,774 prescriptions and refills. In total Amy D Kingman wrote 15,861 Medicare prescriptions that cost $2.7M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Rosuvastatin Calcium Generic | 1,774 | 4,138 | 471 | $21K |
| Ezetimibe Generic | 1,567 | 3,526 | 397 | $29K |
| Metoprolol Succinate Generic | 1,379 | 3,194 | 358 | $18K |
| Spironolactone Generic | 839 | 1,622 | 217 | $6,378 |
| Atorvastatin Calcium Generic | 790 | 1,936 | 230 | $8,652 |
| Eliquis Apixaban | 719 | 1,064 | 137 | $612K |
| Amlodipine Besylate Generic | 683 | 1,614 | 190 | $3,317 |
| Furosemide Generic | 567 | 1,253 | 164 | $3,193 |
| Carvedilol Generic | 536 | 1,260 | 156 | $4,844 |
| Clopidogrel Clopidogrel Bisulfate | 522 | 1,179 | 133 | $5,670 |
| Losartan Potassium Generic | 441 | 1,063 | 132 | $3,695 |
| Repatha Sureclick Evolocumab | 437 | 732 | 98 | $413K |
| Farxiga Dapagliflozin Propanediol | 423 | 558 | 85 | $308K |
| Entresto Sacubitril/Valsartan | 405 | 617 | 80 | $398K |
| Nifedipine Er Nifedipine | 305 | 527 | 56 | $5,922 |
Brand drugs: 2,763 claims; generic drugs: 13,098 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Amy D Kingman $819 ($819 in general payments such as food, travel and fees) from 14 companies. The largest payer was Abbott Laboratories with $252.
| Company | Payments | Amount |
|---|---|---|
| Abbott Laboratories ABT | 2 | $252 |
| Alnylam Pharmaceuticals Inc. ALNY | 2 | $143 |
| Boston Scientific Corporation BSX | 4 | $71.46 |
| Merck Sharp & Dohme LLC MRK | 3 | $65.18 |
| ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) | 2 | $41.9 |
| Esperion Therapeutics, Inc. ESPR | 2 | $41.74 |
| Novartis Pharmaceuticals Corporation NVS | 2 | $40.06 |
| Pfizer Inc. PFE | 2 | $37.53 |
| AstraZeneca Pharmaceuticals LP AZN | 2 | $32.69 |
| Philips North America LLC PHG | 1 | $22.06 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.